These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3481947)

  • 21. [Aerosol therapy with proteolytic enzymes and hormonal preparations in tuberculosis and nonspecific pulmonary diseases].
    Ginzburg ZI; Kniazhetskiĭ SM; Kolesnikova IS
    Probl Tuberk; 1969; 47(5):48-52. PubMed ID: 5367971
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapy of leukoplakia with subtoxic vitamin A doses].
    Wannenmacher MF; Tetsch P; Esser E
    Dtsch Zahnarztl Z; 1972 Feb; 27(2):154-8. PubMed ID: 4501257
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical experiences with vitamin A acid derivatives in therapy of leukoplakia of the mouth mucosa].
    Koch H; Schettler D
    Dtsch Zahnarztl Z; 1973 May; 28(5):623-7. PubMed ID: 4513569
    [No Abstract]   [Full Text] [Related]  

  • 24. [Topical tretinoin in the treatment of lichen planus and leukoplakia of the mouth mucosa. A clinical evaluation].
    Boisnic S; Branchet MC; Pascal F; Ben Slama L; Rostin M; Szpirglas H
    Ann Dermatol Venereol; 1994; 121(6-7):459-63. PubMed ID: 7702278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combined effect of hydrocortisone and some water-soluble vitamins on the barrier function of the focus of inflammation].
    Grosman IuS; Koz'minykh EM
    Biull Eksp Biol Med; 1966 Oct; 62(10):41-4. PubMed ID: 6005594
    [No Abstract]   [Full Text] [Related]  

  • 26. Reduction in oral mucosa micronuclei frequency following alpha-tocopherol treatment of oral leukoplakia.
    Benner SE; Wargovich MJ; Lippman SM; Fisher R; Velasco M; Winn RJ; Hong WK
    Cancer Epidemiol Biomarkers Prev; 1994; 3(1):73-6. PubMed ID: 8118389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical study of an aromatic retinoid (Ro 10-9359) for the treatment of oral hyperkeratosis].
    Ehrl PA
    Dtsch Zahnarztl Z; 1980 May; 35(5):554-8. PubMed ID: 7004844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinoid modulation of biomarkers in oral leukoplakia/dysplasia.
    Beenken SW; Huang P; Sellers M; Peters G; Listinsky C; Stockard C; Hubbard W; Wheeler R; Grizzle W
    J Cell Biochem Suppl; 1994; 19():270-7. PubMed ID: 7823600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Successful management of gingival and oral leukoplakia with non-smoking and vitamin B 2 butyrate esther].
    Shimizu M; Tozuka M
    Shikai Tenbo; 1982 Jul; 60(1):201-4. PubMed ID: 6957010
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of enzyme therapy on the microcirculation in the lower extremities in chronic venous insufficiency].
    Sazonov AM; Anan'eva KA; Turaev RN; Biriukov VA
    Vestn Khir Im I I Grek; 1974 Sep; 113(9):43-5. PubMed ID: 4419194
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of apoptosis and bcl-2 protein in topical treatment of oral leukoplakia with isotretinoin.
    Tetè S; Pappalardo S; Rubini C; Salini L; Falco A; Perfetti EG
    Minerva Stomatol; 1999 Sep; 48(9):411-8. PubMed ID: 10638174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Tropical treatment of oral leukoplakia with 5-fluorouracil].
    Montero ED; Di Piramo S
    An Fac Odontol; 1970 Dec; (14):5-13 passim. PubMed ID: 5293574
    [No Abstract]   [Full Text] [Related]  

  • 33. [Oral leukoplasia].
    Tercedor J; Ródenas JM; López Hernández B; Herranz MT
    Med Clin (Barc); 1997 Sep; 109(9):358-9. PubMed ID: 9379774
    [No Abstract]   [Full Text] [Related]  

  • 34. A review of the use of antioxidant supplements in the treatment of human oral leukoplakia.
    Kaugars GE; Silverman S; Lovas JG; Brandt RB; Thompson JS; Singh VN
    J Cell Biochem Suppl; 1993; 17F():292-8. PubMed ID: 8412207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Histological and histochemical changes occurring in the use of a helium-neon laser in complicated wounds].
    Burgidzhieva T; Bradinska A; Pranchev N
    Akush Ginekol (Sofiia); 1985; 24(6):69-75. PubMed ID: 4091215
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of vitamin A in the treatment of leukoplakia.
    Shourje KL; Biviji AT; Bhatt AP
    J Indian Dent Assoc; 1971 Aug; 43(8):167-70. PubMed ID: 5287219
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral proliferative verrucous leukoplakia (PVL); open trial of surgery compared with combined therapy using surgery and methisoprinol in papillomavirus-related PVL.
    Femiano F; Gombos F; Scully C
    Int J Oral Maxillofac Surg; 2001 Aug; 30(4):318-22. PubMed ID: 11518355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of 13-cis-retinoic acid in the treatment of oral leukoplakia: short-term observations.
    Kaugars G; Silverman S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Mar; 79(3):264-5. PubMed ID: 7620998
    [No Abstract]   [Full Text] [Related]  

  • 39. [Elaboration of the method of electrophoretic administration of ascorbic acid into the bone capsule of the labyrinth in experimental studies].
    Gukovich VA; Fedotov AF
    Vestn Otorinolaringol; 1973; 35(1):65-9. PubMed ID: 4781551
    [No Abstract]   [Full Text] [Related]  

  • 40. [Topical tretinoin in the treatment of lichen planus and leukoplakia of the oral mucosa. A biochemical evaluation of the keratinization].
    Branchet MC; Boisnic S; Pascal F; Ben Slama L; Rostin M; Szpirglas H
    Ann Dermatol Venereol; 1994; 121(6-7):464-9. PubMed ID: 7535512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.